Resultats de la cerca - Praveen Ramakrishnan Geethakumari
- Mostrar 1 - 10 resultats de 10
-
1
-
2
-
3
Increasing Colon Cancer Screening in Primary Care Among African Americans per Ronald E. Myers, Randa Sifri, Constantine Daskalakis, Melissa DiCarlo, Praveen Ramakrishnan Geethakumari, J Cocroft, Christen Minnick, Nancy Brisbon, Sally W. Vernon
Publicat 2014Artigo -
4
A phase 2, multicentre, open‐label trial (<scp>ACE‐LY</scp>‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma per Paolo Strati, Morton Coleman, Rebecca Champion, Shuo Ma, Caterina Patti, Moshe Levy, Izidore S. Lossos, Praveen Ramakrishnan Geethakumari, Selay Lam, Roser Calvo, Kara Higgins, Lihua E. Budde
Publicat 2022Artigo -
5
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer per Young Kwang Chae, Débora De Melo Gagliato, Sachin Gopalkrishna Pai, Benedito A. Carneiro, Nisha Mohindra, Francis J. Giles, Praveen Ramakrishnan-Geethakumari, Joohyuk Sohn, Shuying Liu, Huiqin Chen, Naoto T. Ueno, Gabriel N. Hortobágyi, Ana M. González-Angulo
Publicat 2016Artigo -
6
Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study per Pallawi Torka, Natalie S. Grover, Timothy Voorhees, Reem Karmali, Kaitlin Annunzio, Marcus P. Watkins, Andrea Anampa‐Guzmán, Heather Reves, Montreh Tavakkoli, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey Shouse, Adam J. Olszewski, Narendranath Epperla
Publicat 2025Artigo -
7
CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carb... per Joseph P. McGuirk, Constantine S. Tam, Nicolaus Kröger, Peter A. Riedell, Hemant S. Murthy, Phoebe Joy Ho, Joseph E. Maakaron, Edmund K. Waller, Farrukh T. Awan, Paul Shaughnessy, Armin Ghobadi, Michael Bishop, Ana Alfonso Piérola, Michael Dickinson, Praveen Ramakrishnan Geethakumari, Ainsley Ross, William B. Stevens, Huansheng Xu, Anna Ma, Sarah Beaussant-Cohen, Richard T. Maziarz, Carlos Bachier
Publicat 2022Artigo -
8
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers per Timothy Voorhees, Eric McLaughlin, Pallawi Torka, Jorge A. Florindez, Na Hyun Kim, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish Ayyappan, Lauren Shea, Miriam M. Cortese‐Krott, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Mehdi Hamadani, Natalie S. Grover, Narendranath Epperla
Publicat 2025Artigo -
9
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant per Michael Scordo, Trent Wang, Kwang Woo Ahn, Yue Chen, Sairah Ahmed, Farrukh T. Awan, Amer Beitinjaneh, Andy Chen, Victor A. Chow, Bhagirathbhai Dholaria, Narendranath Epperla, Umar Farooq, Nilanjan Ghosh, Natalie S. Grover, Nada Hamad, Gerhard Hildebrandt, Leona Holmberg, Sanghee Hong, David J. Inwards, Antonio Martin Jimenez-Jimenez, Reem Karmali, Vaishalee P. Kenkre, Farhad Khimani, Evgeny Klyuchnikov, Maxwell M. Krem, Pashna N. Munshi, Yago Nieto, Tim Prestidge, Praveen Ramakrishnan Geethakumari, Andrew R. Rezvani, Peter A. Riedell, Sachiko Seo, Nirav N. Shah, Melhem Solh, Jean A. Yared, Mohamed A. Kharfan‐Dabaja, Alex F. Herrera, Mehdi Hamadani, Craig S. Sauter
Publicat 2021Artigo -
10
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure per Sonali M. Smith, James Godfrey, Kwang Woo Ahn, Alyssa DiGilio, Sairah Ahmed, Vaibhav Agrawal, Veronika Bachanová, Ulrike Bacher, Asad Bashey, Javier Bolaños‐Meade, Mitchell S. Cairo, Andy Chen, Saurabh Chhabra, Edward A. Copelan, Parastoo B. Dahi, Mahmoud Aljurf, Umar Farooq, Siddhartha Ganguly, Mark Hertzberg, Leona Holmberg, David J. Inwards, Abraham S. Kanate, Reem Karmali, Vaishalee P. Kenkre, Mohamed A. Kharfan‐Dabaja, Andreas K. Klein, Hillard M. Lazarus, Matthew Mei, Alberto Mussetti, Taiga Nishihori, Praveen Ramakrishnan Geethakumari, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Nirav N. Shah, Álvaro Urbano-Ispízua, Ravi Vij, Julie M. Vose, Anna Sureda, Mehdi Hamadani
Publicat 2018Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Oncology
Lymphoma
Biology
Astrobiology
Chemotherapy
Physics
Refractory (planetary science)
Surgery
Biochemistry
Cancer
Chemoimmunotherapy
Cohort
Gastroenterology
Immunology
Progression-free survival
Rituximab
Transplantation
Adverse effect
Antibody
Antibody-drug conjugate
Astronomy
B-cell lymphoma
Breast cancer
Brentuximab vedotin
CRISPR
Cancer research
Carmustine
Cell